Unfortunately for some shareholders, the Cantel Medical (NYSE:CMD) share price has dived 50% in the last thirty days...
Cantel (CMD) delivered earnings and revenue surprises of -10.29% and -1.60%, respectively, for the quarter ended January 2020. Do the numbers hold clues to what lies ahead for the stock?
Cantel Medical Corp. (NYSE: CMD) announced today specific areas of focus and associated actions to combat the COVID-19 virus. In these unprecedented times, the company is concentrating on enhanced production, product innovation and value-add COVID-19 education in support of first-responders and other healthcare professionals.
Cantel Medical Corp. (NYSE: CMD) today announced financial results for its second quarter ended January 31, 2020.
CANTEL MEDICAL CORP. (NYSE: CMD) announced today several business and financial updates in light of the ongoing COVID pandemic.
CANTEL MEDICAL CORP. (NYSE: CMD) ("Cantel" or the "Company") today announced the pricing of its offering of $140 million aggregate principal amount of 3.25% convertible senior notes due 2025 (the "Notes") in a private offering only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The Company also granted the initial purchasers of the Notes an option to purchase, for settlement within a period of 13 days from, and including, the date on which the notes are first issued, up to an additional $28.0 million aggregate principal amount of Notes in the private placement. The issuance and sale of the Notes is scheduled to settle on or about May 15, 2020, subject to customary closing conditions.
CANTEL MEDICAL CORP. (NYSE:CMD) ("Cantel" or the "Company") today announced the sale of $28 million in aggregate principal amount of its 3.25% convertible senior notes due 2025 in respect of the Company's previously announced private offering of the notes to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), pursuant to the full exercise by the initial purchasers of their option to purchase additional notes. The Company has issued a total of $168 million aggregate principal amount of the notes pursuant to such offering.
Today, we'll introduce the concept of the P/E ratio for those who are learning about investing. To keep it practical...
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
CANTEL MEDICAL CORP. (NYSE: CMD) ("Cantel" or the "Company") today announced its intention to offer, subject to market and other conditions, $150 million aggregate principal amount of convertible senior notes due 2025 (the "Notes") in a private offering only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The Company also intends to grant the initial purchasers of the Notes an option to purchase up to an additional $22.5 million aggregate principal amount of Notes in the private placement.
CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its second quarter ended January 31, 2020 on Thursday, March 5, 2020 before the market opens, and hold a conference call to discuss the results at 8:30 a.m. ET.
Today we'll look at Cantel Medical Corp. (NYSE:CMD) and reflect on its potential as an investment. Specifically, we're...
Cantel (CMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cantel (CMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its third quarter ended April 30, 2020 on Thursday, June 4, 2020 before the market opens, and hold a conference call to discuss the results at 8:30 a.m. ET.
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […]
Details the CEO buys this past week for Cantel Medical and OPKO Health Continue reading...
Q2 2020 Cantel Medical Corp Earnings Call